A detailed history of Lsv Asset Management transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Lsv Asset Management holds 15,900 shares of CRL stock, worth $2.99 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,900
Holding current value
$2.99 Million
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025

BUY
$99.75 - $151.89 $1.59 Million - $2.42 Million
15,900 New
15,900 $2.41 Million
Q4 2017

Feb 01, 2018

SELL
$100.43 - $118.09 $2.66 Million - $3.13 Million
-26,500 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$96.72 - $109.26 $2.56 Million - $2.9 Million
26,500
26,500 $2.86 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.58B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Lsv Asset Management Portfolio

Follow Lsv Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.